Home
Responsibility
Research practices
Public disclosure of clinical research

Corporate Responsibility Report 2008

Public disclosure of clinical research

Pharmaceutical companies are legally required to disclose all relevant data from clinical trials to the appropriate regulatory authorities when seeking approval for a new medicine.

After approval, sponsors have a continuing obligation to provide regulatory authorities with updated safety information from clinical trials. Read more about patient safety

Safety and efficacy information is provided to doctors through prescribing information which is approved by regulators.

Public disclosure of our research is fundamental to advancing medical science and informing prescribers and patients about scientific findings relating to our medicines. Our Clinical Trial Register was launched in 2004 and is designed to supplement prescribing information and publications in the scientific literature. It contains data relating to marketed medicines and serves as a resource for researchers, medical professionals and the public to use alongside locally approved prescribing information. An improved Clinical Study Register, launched in 2008, has replaced the previous Register and now also includes protocol summaries and enhanced searching capabilities. Read a case study on how the new register is helping to improve access to clinical trials information.

Read our position statement on disclosure of clinical trial information